Your browser doesn't support javascript.
loading
Dosing patterns, toxicity, and outcomes in patients treated with first-line sunitinib for advanced renal cell carcinoma in community-based practices.
Schnadig, Ian D; Hutson, Thomas E; Chung, Hsingwen; Dhanda, Rahul; Halm, Melissa; Forsyth, Michael; Vogelzang, Nicholas J.
Afiliação
  • Schnadig ID; Compass Oncology, Tualatin, OR; McKesson Specialty Health, The Woodlands, TX. Electronic address: Ian.Schnadig@USONCOLOGY.com.
  • Hutson TE; Texas Oncology at Baylor Charles A. Sammons Cancer Center, Dallas, TX.
  • Chung H; McKesson Specialty Health, The Woodlands, TX.
  • Dhanda R; McKesson Specialty Health, The Woodlands, TX.
  • Halm M; McKesson Specialty Health, The Woodlands, TX.
  • Forsyth M; McKesson Specialty Health, The Woodlands, TX.
  • Vogelzang NJ; Comprehensive Cancer Centers of Nevada, Las Vegas, NV.
Clin Genitourin Cancer ; 12(6): 413-21, 2014 Dec.
Article em En | MEDLINE | ID: mdl-25163396

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirróis / Carcinoma de Células Renais / Indóis / Neoplasias Renais / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirróis / Carcinoma de Células Renais / Indóis / Neoplasias Renais / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article